Key Takeaways
- Bankable funds H-1B pharmacy businesses up to $5M based on documented revenue
- No green card, no permanent residency, no citizenship required for funding
- SBA March 2026 rule eliminated H-1B owners from all SBA 7(a) loan access
- 48-hour funding decisions — faster than any bank or SBA lender
- Check your Bankability Score in 30 seconds — no SSN upload
Independent pharmacies are one of the most capital-intensive healthcare retail businesses. Prescription drug inventory costs $300,000 to $800,000 for a typical independent pharmacy. PBM (pharmacy benefit manager) reimbursements arrive net-30 while drugs must be purchased upfront. The inventory-to-reimbursement gap creates a perpetual working capital need.
H-1B pharmacists who own independent pharmacies are serving communities that depend on them — particularly South Asian and Hispanic communities where language-concordant pharmacy care matters enormously. These pharmacists built businesses despite significant capital barriers. The March 2026 SBA rule eliminated their primary source of affordable working capital.
The March 2026 SBA rule eliminated H-1B pharmacy businesses from all 7(a) access. Bankable provides a direct path to revenue-based funding without any citizenship test.
Capital Uses for H-1B Pharmacy Operators
- Drug Inventory Financing: Prescription drug inventory must be purchased from wholesalers (McKesson, Cardinal, AmerisourceBergen) before PBM reimbursement arrives.
- PBM Reimbursement Bridge: PBM payments arrive net-30 to net-60 after dispensing. Bankable bridges the gap between dispensing cost and reimbursement.
- 340B Program Capital: 340B eligible pharmacies require working capital to participate in the program and maximize discounted drug access.
- Compounding Lab Equipment: Pharmacies adding compounding services require specialized equipment and USP 797/800 compliant infrastructure.
- Point of Care Testing: Adding clinical services (COVID, flu, strep testing) requires reagent inventory and equipment investment.
| Funding Source | H-1B Eligible? | Max Amount | Speed |
|---|---|---|---|
| SBA 7(a) — March 2026+ | No — US citizens only | $5M | 30–90 days |
| Traditional Banks | Rarely | Varies | 3–6 weeks |
| Bankable | Always yes | $5M | 48 hours |
For the full SBA alternative landscape for H-1B business owners, see our SBA alternative guide. Check your Bankability Score in 30 seconds to see your preliminary funding range.
Frequently Asked Questions
Yes. Bankable funds pharmacy businesses based on documented revenue. No green card or permanent residency required.
Effective March 1, 2026, the SBA requires 100% US citizen ownership. All H-1B business owners are excluded from SBA 7(a) loans.
Minimum $50,000 in monthly revenue for initial consideration. Businesses at qualifying revenue levels access initial tranches of $100K to $1M.
48-hour decision from completed application. The Bankability Assessment at /bankability-score/ gives a preliminary range in 30 seconds.
No. Bankable funds H-1B holders as sole applicants based on business revenue alone.
No. Bankable has zero residency requirements. H-1B, L-1, O-1, and other work visa holders all qualify for funding assessment based on business revenue alone.
Effective March 1, 2026, the SBA requires 100% US citizen or national ownership for all 7(a) and 504 programs. H-1B holders are completely excluded regardless of revenue or credit history.
48 hours from completed application. The Bankability Assessment at /bankability-score/ takes 30 seconds and gives a preliminary range immediately.